Home » Newsletters » BioWorld Science

BioWorld Science

June 7, 2001

View Archived Issues

ProstaScint scan aids in imaging early recurrent disease after prostatectomy

Tamsulosin highlighted at AUA meeting

Alexion's therapeutic agonist antibodies show promise against thrombocytopenia

Health Canada approves clinical evaluation of ISAtx-247 for three indications

Long-term benefits of Integrilin emerge from ESPRIT study

Pharmexa creates new genomics company

Berlex commences launch of Campath in U.S.

Phytotherapy compared to alpha-adrenoceptor blockade with tamsulosin in BPH

Corvas completes phase IIa PTCA trial with rNAPc2

AUA news: first use of stem cells to regenerate and restore function in sphincter muscle

The Medicines Company and Ferrer establish Angiomax collaboration

DHEA as a physiological means of treating female sexual dysfunction due to ADS

Selective inhibitors of p38 kinase useful in inflammatory conditions

Merck presents new series of indole-based tyrosine kinase inhibitors

Uroselective alpha1A/1L-adrenoceptor antagonists designed by Italian investigators

GlaxoSmithKline portfolio includes newly patented 5-HT7 antagonists

Novel TNF-alpha inhibitors and potential therapeutic uses reported by Sanofi-Synthelabo

New Celltech compounds useful for disease states associated with angiogenesis

DuPont discovers novel compounds with utility as chemokine receptor modulators

Protarga initiates multinational phase II program for Taxoprexin

Combination gene therapy with the cytokines IL-12 and IFN-alpha under study at Valentis

AltaRex enters HCA collaboration with Epigen

New data confirm broad-spectrum activity of HspE7 for treatment of HPV-related diseases

Potent and selective RXR ligand with hypoglycemic activity identified at Allergan

New CMV retinitis treatment option for AIDS patients available from Roche

Promising phase I trial results reported at AUA for MAb targeting PSMA extracellular domain

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...